Bevacizumab and asthenia 
Bevacizumab and asthenia Patient Reports February 10, 2012
Bevacizumab Side Effects Report #5230838-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 05, 2007. Male patient, 76 years of age, weighting 172.0 lb, was diagnosed with tonsil cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, fatigue, oral intake reduced, weight decreased. Bevacizumab dosage: 10 MG/KG Q 2 WEEKS IV. During the same period patient was treated with ERLOTINIB HYDROCHLORIDE, RADIATION. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5253983-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Feb 28, 2007. Male patient, 76 years of age, weighting 172.0 lb, was diagnosed with tonsil cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, dehydration, vomiting. Bevacizumab dosage: 10 MG/KG Q 2 WEEKS IV. During the same period patient was treated with ERLOTINIB HYDROCHLORIDE, ERLOTINIB HYDROCHLORIDE, CISPLATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5224744-7
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on Jan 29, 2007. Male patient, 72 years of age, weighting 186.0 lb, was diagnosed with prostate cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, chills, dehydration, fatigue, mucosal inflammation, myalgia, nausea , pyrexia, unevaluable event. Bevacizumab dosage: 455 MG X1 IV. During the same period patient was treated with DOCETAXEL, CHEMO, LISINOPRIL, POTASSIUM ACETATE, FERROS GLUCONATE, FUROSEMIDE, GLYBURIDE, METOPROLOL TARTRATE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5469617-X
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 25, 2007. Female patient, weighting 99.21 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, asthenia, fatigue, gastrointestinal haemorrhage, syncope. Bevacizumab dosage: 480MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient recovered.
Bevacizumab Side Effects Report #4760940-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on Aug 18, 2005. Female patient, 63 years of age, weighting 164.2 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, body temperature decreased, bundle branch block, chest pain
, chills, computerised tomogram abnormal, crepitations, dizziness , dysphonia. Bevacizumab dosage: 1118 MG, Q3W, INTRAVENOUS. During the same period patient was treated with ATIVAN, EFFEXOR, COMPAZINE, WARFARIN, DOCUSATE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4971693-5
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 27, 2006. Female patient, 63 years of age, weighting 164.2 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, bundle branch block left, chest pain
, chills, computerised tomogram abnormal, crepitations, dilatation ventricular, dizziness , dysphonia. Bevacizumab dosage: 1118 MG, Q3W, INTRAVENOUS. During the same period patient was treated with ATIVAN, EFFEXOR, VITAMIN, COMPAZINE, WARFARIN, DOCUSATE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4663561-3
Bevacizumab side effect was reported by a Physician from on Apr 29, 2005. Female patient, 56 years of age, weighting 250.2 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, blood pressure systolic increased, bradycardia, cardiac enzymes increased, cerebrovascular accident, cheyne-stokes respiration, electrocardiogram st segment elevation, emphysema, fatigue. Bevacizumab dosage: 15 MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with ATENOLOL, VERAPAMIL, LEVOXINE, WARFARIN, VITAMIN B6. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #4899738-1
Bevacizumab side effect was reported by a Physician from UNITED STATES on Jan 17, 2006. Female patient, 48 years of age, weighting 222.0 lb, was diagnosed with ovarian cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal adhesions, activated partial thromboplastin time prolonged, asthenia, atelectasis, atrial fibrillation
, blood creatine phosphokinase increased, blood lactic acid increased, blood ph decreased, blood sodium decreased. Bevacizumab dosage: UNK, Q3W; INTRAVENOUS; 15MG/KG, Q3W;. During the same period patient was treated with SENNA, ESTROGENIC HORM SUBSTANCES, WARFARIN, LISINOPRIL, EPOETIN ALFA, PREDNISONE, DECADRON. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5782996-9
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 18, 2008. Male patient, weighting 156.5 lb, was diagnosed with oesophageal carcinoma, type 2 diabetes mellitus, hypertension, coronary artery disease
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, atrial fibrillation . Bevacizumab dosage: 1200 MG, UNK. During the same period patient was treated with ERLOTINIB, TAXOL, CARBOPLATIN, FLUOROURACIL, GLIPIZIDE, BENAZEPRIL HYDROCHLORIDE, PLAVIX. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5416836-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Aug 15, 2007. Male patient, 81 years of age, weighting 143.3 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, asthenia, dehydration, fatigue, hypernatraemia, hypokalaemia, oral intake reduced, weight decreased. Bevacizumab dosage: 1050 MG Q21 DAYS IV. During the same period patient was treated with PEMETREXED, ERLOTINIB, PROSCAR, INDAPAMIDE, LISINOPRIL, TERAZOSIN, LIPITOR, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5025139-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on June 03, 2006. Male patient, 76 years of age, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, back pain , blood alkaline phosphatase increased, blood sodium decreased, decreased appetite, depression . Bevacizumab dosage: 1238 MG. During the same period patient was treated with GEMZAR, CAROPLATN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5300838-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 17, 2007. Male patient, 75 years of age, weighting 196.2 lb, was diagnosed with non-small cell lung cancer, bone marrow failure and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, cough, decubitus ulcer, deep vein thrombosis
, diarrhoea, haemoglobin decreased, hyperhidrosis, lung infiltration, oxygen saturation decreased. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with TAXOTERE, OXALIPLATIN, DILAUDID, FILGRASTIM, DURAGESIC, TUSSINEX, PHENERGAN, HYCODAN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5277917-1
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 12, 2007. Male patient, 68 years of age, weighting 160.7 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, confusional state, leukoencephalopathy. Bevacizumab dosage: unknown. During the same period patient was treated with DOCETAXEL, CAROBPLATIN. Patient died on 03/09/2007.
Bevacizumab Side Effects Report #5287051-2
Bevacizumab side effect was reported by a Physician from UNITED STATES on Mar 19, 2007. Male patient, 68 years of age, weighting 160.7 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: arteriosclerosis, asthenia, bacteria urine identified, blood glucose increased, cerebrovascular disorder, confusional state, depressed level of consciousness, drooling, leukoencephalopathy. Bevacizumab dosage: unknown. During the same period patient was treated with DOCETAXEL, CARBOPLATIN, LOVASTATIN, ATENOLOL, LISINOPRIL, ASPIRIN. Patient was hospitalized. Patient died on 03/09/2007.
Bevacizumab Side Effects Report #5147188-5
Bevacizumab side effect was reported by a Health Professional from CANADA on Oct 18, 2006. Male patient, 65 years of age, weighting 163.1 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, colitis, cough, hypokalaemia, ileus, leukocytosis, nausea
, pneumothorax, sputum discoloured. Bevacizumab dosage: 15 MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with CISPLATIN, GEMCITABINE, DOCUSATE, PROCHLORPERAZINE, SENOKOT, ZANTAC, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5387633-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 06, 2007. Female patient, weighting 150.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, asthenia, dehydration, dizziness
, hypokalaemia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ALIMTA, CARBOPLATIN, RADIATION. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5395518-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 19, 2007. Female patient, weighting 150.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, asthenia, dehydration, dizziness
, hypokalaemia. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ALIMTA, CARBOPLATIN, RADIATION, FOLIC ACID. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5468893-7
Bevacizumab side effect was reported by a Physician from UNITED STATES on Sept 11, 2007. Male patient, weighting 163.4 lb, was diagnosed with non-small cell lung cancer, hypertension, chronic obstructive pulmonary disease, iron deficiency, musculoskeletal chest pain and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, bacterial sepsis, blood creatinine decreased, chest discomfort, haemoglobin decreased, hepatic cirrhosis. Bevacizumab dosage: 1110 MG, Q3W. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, LOTENSIN, ADVAIR DISKUS, ALBUTEROL, NORVASC, FEOSOL, VICODIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5501797-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 16, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, back pain
. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with CISPLATIN, GEMCITABINE, HYDROMORPHONE, DILAUDID, DECADRON, PANTOPRAZOLE, METOCLOPRAMIDE, PROCHLORPERAZINE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5584606-2
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 02, 2008. Female patient, weighting 178.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, atrial fibrillation
, tremor. Bevacizumab dosage: 15 MG/KG, Q3W. During the same period patient was treated with ZYRTEC, HYDROXYZINE, SINGULAIR, REGLAN, BONIVA, CELEBREX, ADVAIR DISKUS. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5914067-2
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 01, 2008. Female patient, weighting 133.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, asthenia. Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with ALIMTA, GEMZAR. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5926658-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 16, 2008. Female patient, weighting 133.0 lb, was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, asthenia. Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with ALIMTA, GEMZAR, AMLODIPINE, OXYBUTYNIN, ASPIRIN, FOLIC ACID, NEXIUM, ATARAX. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #6126856-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 13, 2009. Male patient was diagnosed with non-small cell lung cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, pyrexia. Bevacizumab dosage: 10 ML/KG, DAYS 1+15. During the same period patient was treated with PEMETREXED, GEMCITABINE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #4558865-9
Bevacizumab side effect was reported by a Consumer or non-health professional from on Jan 21, 2005. Male patient, weighting 132.3 lb, was diagnosed with neuroendocrine tumour and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, blood creatine phosphokinase increased, dehydration, fall
, hypoglycaemia, liver function test abnormal, pollakiuria, troponin increased. Bevacizumab dosage: 5 MG/KG D 1 + 15 INTRAVENOU. During the same period patient was treated with TEMOZOLOMIDE, ATIVAN, COMPAZINE, CREON, DOXAZOSIN, LASIX, LISINOPRIL. Patient died on 12/26/2004.Bevacizumab Side Effects Report #5724177-0
Bevacizumab side effect was reported by a Physician from UNITED STATES on Apr 22, 2008. Female patient was diagnosed with neuroendocrine carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, hypovolaemia. Bevacizumab dosage: 7.5 MG/KG, Q3W. During the same period patient was treated with OXALIPLATIN, XELODA, ACTONEL, DARVOCET, OXYCONTIN, TEMAZEPAM, COMPAZINE, COLACE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5730735-X
Bevacizumab side effect was reported by a Physician from UNITED STATES on May 01, 2008. Female patient was diagnosed with neuroendocrine carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, hypovolaemia. Bevacizumab dosage: 7.5 MG/KG, Q3W. During the same period patient was treated with OXALIPLATIN, XELODA, ACTONEL, DARVOCET, OXYCONTIN, TEMAZEPAM, COMPAZINE, COLACE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5508349-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 22, 2007. Female patient, weighting 113.0 lb, was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, constipation
. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with ERLOTINIB, TAXOL, CARBOPLATIN. Patient was hospitalized. Patient died on 09/03/2007.Bevacizumab Side Effects Report #5517410-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 06, 2007. Female patient, weighting 113.0 lb, was diagnosed with neoplasm malignant and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, constipation
. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with ERLOTINIB, TAXOL, CARBOPLATIN. Patient was hospitalized. Patient died on 09/03/2007.Bevacizumab Side Effects Report #5087366-7
Bevacizumab side effect was reported by a Health Professional from GERMANY on Aug 01, 2006. Male patient, 71 years of age, weighting 149.9 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, cerebrovascular accident, gliosis, irritability, strabismus, weight decreased. Bevacizumab dosage: 10 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with INTERFERON ALPHA, ACETAMINOPHEN, ATACAND, ZOMETA, MOVICOL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5062456-3
Bevacizumab side effect was reported by a Physician from GERMANY on July 11, 2006. Male patient, 69 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anxiety
, asthenia, body temperature increased, dizziness , nervous system disorder, pain in extremity. Bevacizumab dosage: 10 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with INTERFERON ALPHA, INSULIN, INSULIN GLARGINE, MEGNESIUM. Patient recovered.Bevacizumab Side Effects Report #5164862-5
Bevacizumab side effect was reported by a Physician from GERMANY on Nov 08, 2006. Male patient, 69 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, body temperature increased, dizziness
, nervous system disorder, pain in extremity, tremor. Bevacizumab dosage: 10 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with INTERFERON ALPHA, INSULIN, INSULIN GLARGINE, MAGNESIUM SULPHATE. Patient recovered.Bevacizumab Side Effects Report #5761915-5
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 22, 2008. Female patient, 58 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, pyrexia. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with INTERFERON ALFA, SKENAN, ACTISKENAN, INNOHEP, LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, LYRICA. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5798643-6
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on June 20, 2008. Female patient was diagnosed with metastatic renal cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, pyrexia. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with INTERFERON ALFA, SKENAN, MORPHINE, INNOHEP, LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, LYRICA, TANAKAN, VASTAREL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #4897413-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 30, 2006. Female patient, weighting 114.6 lb, was diagnosed with metastasis, transitional cell carcinoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, confusional state, dysarthria, fatigue, foaming at mouth, grand mal convulsion, headache
, hypertensive encephalopathy, loss of consciousness. Bevacizumab dosage: 15MG/KG -806MG, 834MG, 780MG ONCE EVERY 3 WEEKS IV DRIP. Patient recovered.Bevacizumab Side Effects Report #4887657-6
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Jan 19, 2006. Female patient, 71 years of age, weighting 126.1 lb, was diagnosed with mesothelioma
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, chest pain , dehydration, gastrointestinal haemorrhage, haemoglobin decreased, oedema peripheral, thrombosis. Bevacizumab dosage: 858 MG ., QD/DAYS IV. During the same period patient was treated with TARCEVA. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5389966-3
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on July 16, 2007. Female patient, 46 years of age, weighting 166.0 lb, was diagnosed with lung cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, dizziness
, headache , nausea , oral intake reduced, reversible posterior leukoencephalopathy syndrome. Bevacizumab dosage: 1200MG, 1175MG, 1125MG. Patient recovered.Bevacizumab Side Effects Report #5897910-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 24, 2008. Male patient, 65 years of age, weighting 153.0 lb, was diagnosed with head and neck cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, blood culture positive, constipation , dehydration, faecal incontinence, hypotension, lethargy, pneumonia aspiration. Bevacizumab dosage: 337 MG QOWK X 4. During the same period patient was treated with TAXOTERE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5265812-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 12, 2007. Female patient, 68 years of age, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, confusional state, haematochezia, haemoglobin decreased, mental status changes, neuropathy, oral intake reduced, prothrombin time abnormal, sedation. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, TOPROL, TIMOLOL MALEATE, NEXIUM, COUMADIN, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5919069-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Oct 14, 2008. Male patient, 66 years of age, weighting 200.2 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, citrobacter infection, pathogen resistance, urinary retention, urinary tract infection
, wheelchair user. Bevacizumab dosage: 908MG Q2WKS IV. During the same period patient was treated with TEMOZOLOMIDE, ZESTRIL, PREVACID, CIPRO, AVODART, KEPPRA, DECADRON. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5836369-0
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 06, 2008. Female patient, 61 years of age, weighting 90.40 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aphasia
, asthenia, condition aggravated, fall , muscular weakness, neurological symptom. Bevacizumab dosage: 10MG/KG Q 2 WEEKS IV DRIP 3 INFUSIONS. During the same period patient was treated with INSULIN, INSULIN REGULAR SLIDING SCALE, CATAPRES, NEURONTIN, CLARITIN, GLUCOPHAGE, PRILOSEC, LISINOPRIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5466830-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 17, 2007. Female patient, 56 years of age, weighting 176.4 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abasia, abscess
, asthenia, convulsion, disease progression, fall , pulmonary mass. Bevacizumab dosage: 805MG IV EVERY 2 WEEKS. During the same period patient was treated with TEMOZOLOMIDE, PROTONIX, SYNTHROID, ASPIRIN, KEPPRA, DECADRON. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5311623-X
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 26, 2007. Male patient was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abasia, alopecia, asthenia, blood glucose increased, crying, dyspnoea, oedema, pneumonitis. Bevacizumab dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, DEXAMETHASONE, LUNESTA, TYLENOL, POTASSIUM ACETATE, LASIX, VYTORIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5826839-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 29, 2008. Male patient, weighting 138.9 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, csf test abnormal, intracranial hypotension, meningitis
, pseudomonas infection, wound complication. Bevacizumab dosage: 10 MG/KG IV Q 2 WEEKS CYCLE 8. During the same period patient was treated with ERLOTINIB, CITALOPRAM HYDROBROMIDE, IMODIUM, LISINOPRIL, LONOX, KEPPRA. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5826843-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on July 29, 2008. Male patient, weighting 138.9 lb, was diagnosed with glioblastoma multiforme and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, csf test abnormal, intracranial hypotension, meningitis
, pseudomonas infection, wound complication. Bevacizumab dosage: 10 MG/KG IV Q 2 WEEKS CYCLE 8. During the same period patient was treated with ERLOTINIB, CITALOPRAM HYDROBROMIDE, IMODIUM, LISINOPRIL, LONOX, KEPPRA. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #4622198-2
Bevacizumab side effect was reported by a Consumer or non-health professional from on Mar 24, 2005. Male patient, weighting 147.7 lb, was diagnosed with gastric cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acute myocardial infarction, aphasia
, asthenia, cerebral infarction, cerebrovascular accident, grand mal convulsion, hypoaesthesia, lacunar infarction, loss of consciousness. Bevacizumab dosage: unknown. During the same period patient was treated with DOCETAXEL, DEXAMETHASONE, COMPAZINE, DECADRON, DILAUDID, ATIVAN, EFFEXOR. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5062789-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on July 24, 2006. Male patient, weighting 190.0 lb, was diagnosed with endocrine neoplasm, pancreatic neoplasm and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal pain
, anaemia, asthenia, fatigue, gastritis erosive, ileus, liver abscess, platelet count decreased, pyrexia. Bevacizumab dosage: 465 MG QS Q2WEEKS IV. During the same period patient was treated with DEXAMETHASONE, LORAZEPAM, GRANISETRON, OXALIPLATIN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5485999-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Oct 01, 2007. Male patient was diagnosed with diffuse large b-cell lymphoma and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, confusional state, dysphagia, faecal incontinence, fatigue, lethargy, lymphoma
, malaise, muscular weakness. Bevacizumab dosage: 15 MG/KG, Q21D. During the same period patient was treated with RITUXAN, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISOLONE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5378967-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on June 20, 2007. Male patient, weighting 154.3 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, pyrexia, white blood cell count decreased. Bevacizumab dosage: 352 MG, Q2W. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5384524-9
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on June 28, 2007. Male patient, weighting 154.3 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, pyrexia. Bevacizumab dosage: 352 MG, Q2W. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5431730-0
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Aug 16, 2007. Male patient was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anorexia, asthenia, blood creatinine increased, blood urea increased, diarrhoea, musculoskeletal chest pain, nausea
, weight decreased. Bevacizumab dosage: 570 MG, Q3W. During the same period patient was treated with CAPECITABINE, IRINOTECAN, KETOPROFEN, LYTOS, TRAMADOL. Patient died on 08/09/2007.Bevacizumab Side Effects Report #5529681-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 21, 2007. Male patient, weighting 149.9 lb, was diagnosed with colorectal cancer metastatic, hypertension and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, diarrhoea, gastrointestinal haemorrhage, renal failure. Bevacizumab dosage: 385 MG, UNK. During the same period patient was treated with IRINOTECAN, FLUOROURACIL, FOLINIC ACID, RAMIPRIL. Patient recovered.
Bevacizumab Side Effects Report #5615409-8
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 22, 2008. Male patient, weighting 192.9 lb, was diagnosed with colorectal cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: anaemia, asthenia. Bevacizumab dosage: 450 MG, Q2W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, FENTANYL TRANSDERMAL SYSTEM, DILAUDID, COMPAZINE, HYDROCODONE BITARTRATE, ROBAXIN, ZOFRAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5403211-1
Bevacizumab side effect was reported by a Physician from UNITED STATES on July 17, 2007. Female patient, 53 years of age, weighting 140.0 lb, was diagnosed with colon cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, asthenia, dehydration, ileus, intestinal perforation, nausea
, oral intake reduced, sepsis , small intestinal obstruction. Bevacizumab dosage: 5MG/KG Q2W IV. During the same period patient was treated with COUMADIN, PROZAC, SYNTHROID, VICODIN, COMPAZINE. Patient was hospitalized. Patient died on 06/30/2007.Bevacizumab Side Effects Report #4934938-3
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Mar 03, 2006. Male patient, 73 years of age, weighting 141.0 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, bacteraemia, dehydration, dyspnoea, hypokalaemia, international normalised ratio increased, pulmonary embolism
, renal failure acute, staphylococcal infection . Bevacizumab dosage: 5 MG/KG DAY 1 IV. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, ERLOTINIB, ACTOS, COMPAZINE, GLIPIZIDE. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5828353-8
Bevacizumab side effect was reported by a Pharmacist from UNITED STATES on July 29, 2008. Male patient, 57 years of age, weighting 273.0 lb, was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, dyspnoea, hypoaesthesia, muscle spasms, neuropathy peripheral. Bevacizumab dosage: 600 MG ONCE IV. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5958764-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Nov 04, 2008. Female patient was diagnosed with colon cancer and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, blood creatinine increased, dehydration, diarrhoea, fatigue, lethargy, malaise. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5582091-8
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 31, 2007. Female patient was diagnosed with cervix carcinoma, pain
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, decreased appetite, dysphonia, fatigue, renal failure, urine output decreased. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with CISPLATIN, TOPOTECAN, VERAPAMIL, HYDROCHLOROTHIAZIDE, METOPROLOL TARTRATE, PERCOCET, MORPHINE, ZOFRAN. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5194459-2
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 15, 2006. Female patient, 62 years of age, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, blood alkaline phosphatase increased, dehydration, escherichia bacteraemia, fall
, haemoglobin decreased, head injury, renal failure, sepsis syndrome. Bevacizumab dosage: 10 MG/KG, INTRAVENOUS. During the same period patient was treated with PACLITAXEL, RAMIPRIL, VICODIN, DURAGESIC, MACROBID. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5449373-1
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Aug 30, 2007. Female patient was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, dehydration, renal failure. Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with PACLITAXEL, RAMIPRIL, VICODIN, DURAGESIC, MACROBID. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5472031-4
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Sept 18, 2007. Female patient was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, dehydration, renal failure. Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with PACLITAXEL, RAMIPRIL, VICODIN, DURAGESIC, MACROBID. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5545673-5
Bevacizumab side effect was reported by a Health Professional from UNITED STATES on Dec 06, 2007. Female patient was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, blood alkaline phosphatase increased, dehydration, disease recurrence, escherichia sepsis, fall
, haemoglobin decreased, head injury, renal failure. Bevacizumab dosage: 10 MG/KG, UNK. During the same period patient was treated with PACLITAXEL, RAMIPRIL, VICODIN, DURAGESIC, MACROBID. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5745898-X
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 06, 2008. Female patient, weighting 138.9 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, hypoaesthesia, urinary retention. Bevacizumab dosage: 950 MG, Q3W. During the same period patient was treated with OXYCODONE, DICLOFENAC. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5750186-1
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 13, 2008. Female patient, weighting 138.9 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, hypoaesthesia, nuclear magnetic resonance imaging brain abnormal, urinary retention. Bevacizumab dosage: 950 MG, Q3W. During the same period patient was treated with OXYCODONE, DICLOFENAC. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5764272-3
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on May 28, 2008. Female patient, weighting 138.9 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, hypoaesthesia, urinary retention. Bevacizumab dosage: 950 MG, Q3W. During the same period patient was treated with OXYCODONE, DICLOFENAC. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #6068614-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 23, 2009. Female patient was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia. Bevacizumab dosage: 10 MG/KG, Q2W. During the same period patient was treated with TRASTUZUMAB, CYCLOPHOSPHAMIDE, METHOTREXATE. Patient recovered.
Bevacizumab Side Effects Report #6074234-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Jan 28, 2009. Female patient, weighting 138.9 lb, was diagnosed with breast cancer metastatic and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, hypoaesthesia, urinary retention. Bevacizumab dosage: 950 MG, Q3W. During the same period patient was treated with OXYCODONE, DICLOFENAC. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5929960-4
Bevacizumab side effect was reported by a Physician from UNITED STATES on Oct 21, 2008. Female patient, 62 years of age, weighting 129.2 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, asthenia, blood potassium decreased, blood sodium decreased, gastrointestinal haemorrhage, gingival bleeding, haematuria, hypoalbuminaemia, hypotension. Bevacizumab dosage: 15 MG/KG, UNK. During the same period patient was treated with DOCETAXEL, CYCLOPHOSPHAMIDE, DOXORUBICIN, ATENOLOL, DIAZEPAM, VICODIN, AMBIEN. Patient was hospitalized. Patient died on 07/08/2008.Bevacizumab Side Effects Report #5531814-2
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on Nov 21, 2007. Female patient, weighting 147.0 lb, was diagnosed with breast cancer
and was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, blood pressure immeasurable, c-reactive protein increased, cardiac arrest , cardiac disorder, cardiac enzymes increased, cerebral artery embolism, dyspnoea, left ventricular dysfunction. Bevacizumab dosage: 10 MG/M2, UNK. During the same period patient was treated with TAXOL. Patient was hospitalized. Patient died on 09/23/2007.Bevacizumab Side Effects Report #5219068-8
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 24, 2007. Male patient, weighting 191.8 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: aphasia
, asthenia, dysarthria, facial palsy, ischaemic cerebral infarction. Bevacizumab dosage: 870 MG. During the same period patient was treated with LEUCOVORIN CALCIUM, ELOXATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.Bevacizumab Side Effects Report #5354526-7
Bevacizumab side effect was reported by a Physician from UNITED KINGDOM on June 01, 2007. Female patient was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: asthenia, cardiac failure congestive, confusional state, congestive cardiomyopathy, disorientation, ejection fraction decreased, fall
, left ventricular dysfunction, muscular weakness. Bevacizumab dosage: 10 MG/KG, DAYS 1+15. During the same period patient was treated with INTRON A. Patient was hospitalized. Patient died on 04/21/2007.Bevacizumab Side Effects Report #5135261-7
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 24, 2006. Female patient, weighting 121.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: agranulocytosis, asthenia, candidiasis, dehydration, diarrhoea, fatigue, oral intake reduced, white blood cell count decreased. Bevacizumab dosage: 274 MG. During the same period patient was treated with CAMPTOSAR, ELOXATIN, ALOXI, ARANESP, DEXAMETHASONE, IMODIUM, KYTRIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5146918-6
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 07, 2006. Female patient, weighting 121.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: agranulocytosis, asthenia, candidiasis, dehydration, diarrhoea, lung infiltration, oral intake reduced, pleural effusion, respiratory distress. Bevacizumab dosage: 274 MG. During the same period patient was treated with IRINOTECAN, OXALIPLATIN, ALOXI, ARANESP, DEXAMETHASONE, IMODIUM, KYTRIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5150484-9
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 09, 2006. Female patient, weighting 121.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: agranulocytosis, anorexia, asthenia, candidiasis, dehydration, diarrhoea, fatigue, lung infiltration, pleural effusion. Bevacizumab dosage: 274 MG. During the same period patient was treated with CAMPTOSAR, ELOXATIN, ALOXI, ARANESP, DEXAMETHASONE, IMODIUM, KYTRIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5150512-0
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 09, 2006. Female patient, weighting 121.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: agranulocytosis, anorexia, asthenia, candidiasis, dehydration, diarrhoea, fatigue, lung infiltration, pleural effusion. Bevacizumab dosage: 274 MG. During the same period patient was treated with CAMPTOSAR, OXALIPLATIN, ALOXI, ARANESP, DEXAMETHASONE, IMODIUM, KYTRIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5152067-3
Bevacizumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 13, 2006. Female patient, weighting 121.3 lb, was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: agranulocytosis, anorexia, asthenia, candidiasis, dehydration, diarrhoea, fatigue, lung infiltration, pleural effusion. Bevacizumab dosage: 274 MG. During the same period patient was treated with CAMPTOSAR, ELOXATIN, ALOXI, ARANESP, DEXAMETHASONE, IMODIUM, KYTRIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5719067-3
Bevacizumab side effect was reported by a Physician from UNITED STATES on Apr 10, 2008. Female patient was treated with Bevacizumab. After drug was administered, patient experienced the following side effects: abdominal distension, anaemia, aspiration, asthenia, cardiac arrest
, dehydration, diarrhoea, dizziness , electrocardiogram st-t segment abnormal. Bevacizumab dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL. Patient was hospitalized. Patient recovered.